Triple
T1172195
| Position | Surface form | Disambiguated ID | Type / Status |
|---|---|---|---|
| Subject | Vumerity |
E24937
|
entity |
| Predicate | hasRegulatoryApproval |
P24602
|
FINISHED |
| Object | U.S. Food and Drug Administration |
E13297
|
NE FINISHED |
How this triple was built (3 steps)
Every LLM step that produced this triple, in pipeline order — named-entity classification, the disambiguation choices (the exact options shown, with the pick highlighted), and the generated description. The batch + timestamp of each is in the Provenance table below.
NER
Named-entity recognition
gpt-5-mini
Instruction
Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).
Input
Phrase: U.S. Food and Drug Administration | Statement: [Vumerity, hasRegulatoryApproval, U.S. Food and Drug Administration]
NED1
Entity disambiguation (via context triple)
gpt-5-mini-2025-08-07
Target entity: U.S. Food and Drug Administration Context triple: [Vumerity, hasRegulatoryApproval, U.S. Food and Drug Administration]
-
A.
Food and Drug Administration
chosen
The Food and Drug Administration is a U.S. federal agency responsible for protecting public health by regulating food, drugs, medical devices, and other consumer products.
-
B.
Center for Biologics Evaluation and Research
The Center for Biologics Evaluation and Research is the U.S. regulatory body responsible for overseeing the safety, efficacy, and quality of biological products such as vaccines, blood products, and gene therapies.
-
C.
Center for Drug Evaluation and Research
The Center for Drug Evaluation and Research is the U.S. FDA division responsible for overseeing the safety, effectiveness, and quality of prescription and over-the-counter drugs.
-
D.
Office of Regulatory Affairs
The Office of Regulatory Affairs is the U.S. FDA’s primary field organization responsible for inspecting regulated products and manufacturers, enforcing compliance, and overseeing import operations to protect public health.
-
E.
Center for Devices and Radiological Health
The Center for Devices and Radiological Health is the U.S. FDA division responsible for regulating medical devices and radiation-emitting products to ensure their safety and effectiveness.
- F. None of above.
- G. Unsure - the case is ambiguous/there is not enough information to decide.
PD
Predicate disambiguation
gpt-5-mini-2025-08-07
Target predicate: hasRegulatoryApproval Context triple: [Vumerity, hasRegulatoryApproval, U.S. Food and Drug Administration]
-
A.
regulatoryOutcome
Indicates the result or consequence of a regulatory process, such as approval, rejection, modification, or other formal decision made by a regulatory authority regarding an entity or action.
-
B.
supportsRegulation
Indicates that one entity endorses, backs, or advocates for the implementation or continuation of a specific regulation.
-
C.
hasSafetyRegulationCompliance
Indicates that an entity adheres to, satisfies, or is in conformity with specified safety regulations or standards.
-
D.
regulatoryType
Indicates the specific kind or category of regulatory control, rule, or oversight that applies in the given relationship.
-
E.
hasEnvironmentalRegulationCompliance
Indicates that an entity adheres to or fulfills applicable environmental regulations, standards, or compliance requirements.
- F. None of above. chosen
Provenance (5 batches)
The batch behind each pipeline step, in order, with when it ran. Timestamps are batch-level — stages were processed in waves, so the object chain (NER → NED1 → NEDg → NED2) reads in order, but predicate / elicitation batches can sit in a different wave.
| Step | Stage | Batch ID | Status | When |
|---|---|---|---|---|
| creating | Elicitation | batch_69a494082a7c819095004f423f294a64 |
completed | March 1, 2026, 7:31 p.m. |
| NER | Named-entity recognition | batch_69a4bceb3f188190b8b767380fe5986f |
completed | March 1, 2026, 10:25 p.m. |
| NED1 | Entity disambiguation (via context triple) | batch_69ac7f323bbc8190a55fe2101f9561e2 |
completed | March 7, 2026, 7:40 p.m. |
| PD | Predicate disambiguation | batch_69a4bb5656948190b0b1d5446ad06005 |
completed | March 1, 2026, 10:19 p.m. |
| PDg | Predicate description generation | batch_69a4bbd7ff1881908c943ecdfea59e81 |
completed | March 1, 2026, 10:21 p.m. |
Created at: March 1, 2026, 7:45 p.m.